These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8170809

  • 1. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J, Jankowski A, Szozda A.
    Pol Tyg Lek; ; 48(20-22):455-9. PubMed ID: 8170809
    [Abstract] [Full Text] [Related]

  • 2. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS, Shien CY, Chi CS.
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [Abstract] [Full Text] [Related]

  • 3. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 4. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A, Polito C, Del Gado R, Foglia AC.
    Child Nephrol Urol; 2010 Oct; 9(4):200-2. PubMed ID: 3255483
    [Abstract] [Full Text] [Related]

  • 5. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO, Kari JA.
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [Abstract] [Full Text] [Related]

  • 6. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J, Kryński J.
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [Abstract] [Full Text] [Related]

  • 8. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 9. [Administration of levamisole to children with kidney disease exacerbation caused by recurrent respiratory infections].
    Prandota J, Kobylińska J, Lipowska K.
    Pol Tyg Lek; 2006 Jan; 44(28-29):673-6. PubMed ID: 2637440
    [Abstract] [Full Text] [Related]

  • 10. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 11. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
    Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K.
    Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
    [Abstract] [Full Text] [Related]

  • 12. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P, Bianchetti MG, Imoberdorf G, Lütschg J, Reymond D, Oetliker OH.
    Schweiz Med Wochenschr; 1994 May 14; 124(19):801-5. PubMed ID: 8209202
    [Abstract] [Full Text] [Related]

  • 13. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A, Jung A, Bochniewska V, Straz-Zebrowska E.
    Pol Merkur Lekarski; 2000 Sep 14; 9 Suppl 1():25-6. PubMed ID: 11081338
    [Abstract] [Full Text] [Related]

  • 14. T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood.
    Neuhaus TJ, Shah V, Callard RE, Barratt TM.
    Nephrol Dial Transplant; 1995 Sep 14; 10(8):1348-52. PubMed ID: 8538925
    [Abstract] [Full Text] [Related]

  • 15. [Immunological parameters and ultrastructure of blood formed elements in nephrotic syndrome in children].
    Davitaia T, Mandzhavidze N, Tsagareli Z, Korsantia B, Megrelishvili G.
    Georgian Med News; 2006 Mar 14; (132):81-4. PubMed ID: 16636388
    [Abstract] [Full Text] [Related]

  • 16. HLA-DR, -DQB typing of steroid-sensitive idiopathic nephrotic syndrome children in Taiwan.
    Huang YY, Lin FJ, Fu LS, Lan JL.
    Nephron Clin Pract; 2009 Mar 14; 112(2):c57-64. PubMed ID: 19390203
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
    Saeed B, Ossman MI, Sheriff S.
    Saudi J Kidney Dis Transpl; 2006 Dec 14; 17(4):497-502. PubMed ID: 17186683
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 14; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 19. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct 14; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 20. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
    Fu LS, Chi CS.
    Acta Paediatr Taiwan; 2000 Oct 14; 41(2):80-4. PubMed ID: 10927944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.